Fas apoptosis inhibitory molecule enhances CD40 signaling in B cells and augments the plasma cell compartment

Journal of Immunology

Volumn 183, Issue 3, 2009, Pages 1667-1674

  Kaku, Hiroaki ^a   Rothstein, Thomas L ^a  

^a FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD40 ANTIGEN; FAS APOPTOSIS INHIBITORY MOLECULE; IMMUNOGLOBULIN ANTIBODY; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERFERON REGULATORY FACTOR 4; LIPOPOLYSACCHARIDE; PROTEIN; PROTEIN BCL 6; UNCLASSIFIED DRUG; APOPTOSIS REGULATORY PROTEIN; BCL6 PROTEIN, HUMAN; DNA BINDING PROTEIN; FAIM PROTEIN, HUMAN; INTERFERON REGULATORY FACTOR; INTERFERON REGULATORY FACTOR-4;

ANIMAL CELL; ARTICLE; B LYMPHOCYTE; CELL COMPARTMENTALIZATION; CELL DIFFERENTIATION; CONTROLLED STUDY; DOWN REGULATION; IN VITRO STUDY; MALE; MOUSE; NONHUMAN; PLASMA CELL; PRIORITY JOURNAL; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; CELL PROLIFERATION; GENE EXPRESSION REGULATION; GENETICS; HUMAN; METABOLISM; PHYSIOLOGY;

ANTIGENS, CD40; APOPTOSIS REGULATORY PROTEINS; B-LYMPHOCYTES; CELL PROLIFERATION; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION; HUMANS; INTERFERON REGULATORY FACTORS; NF-KAPPA B; SIGNAL TRANSDUCTION;

EID: 68149173333     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0900056     Document Type: Article

References (57)

1. Schneider, T. J., G. M. Fischer, T. J. Donohoe, T. P. Colarusso, and T. L. Rothstein. 1999. A novel gene coding for a Fas apoptosis inhibitory molecule (FAIM) isolated from inducibly Fas-resistant B lymphocytes. J. Exp. Med. 189: 949-956.
2. Rothstein, T. L., J. K. Wang, D. J. Panka, L. C. Foote, Z. Wang, B. Stanger, H. Cui, S. T. Ju, and A. Marshak-Rothstein. 1995. Protection against Fas-dependent Th1-mediated apoptosis by antigen receptor engagement in B cells. Nature 374: 163-165.
3. Foote, L. C., T. J. Schneider, G. M. Fischer, J. K. Wang, B. Rasmussen, K. A. Campbell, D. H. Lynch, S. T. Ju, A. Marshak-Rothstein, and T. L. Rothstein. 1996. Intracellular signaling for inducible antigen receptor-mediated Fas resistance in B cells. J. Immunol. 157: 1878-1885.
4. Segura, M. F., C. Sole, M. Pascual, R. S. Moubarak, M. J. Perez-Garcia, R. Gozzelino, V. Iglesias, N. Badiola, J. R. Bayascas, N. Llecha, et al. 2007. The long form of Fas apoptotic inhibitory molecule is expressed specifically in neurons and protects them against death receptor-triggered apoptosis. J. Neurosci. 27: 11228-11241.
5. Choi, C. Y., K. Reimers, C. Allmeling, S. Kall, Y. H. Choi, and P. M. Vogt. 2007. Inhibition of apoptosis by expression of antiapoptotic proteins in recombinant human keratinocytes. Cell Transplant. 16: 663-674. (Pubitemid 351448280)
6. Yu, L. Y., M. Saarma, and U. Arumae. 2008. Death receptors and caspases but not mitochondria are activated in the GDNF- or BDNF-deprived dopaminergic neurons. J. Neurosci. 28: 7467-7475.
7. Zhong, X., T. J. Schneider, D. S. Cabral, T. J. Donohoe, and T. L. Rothstein. 2001. An alternatively spliced long form of Fas apoptosis inhibitory molecule (FAIM) with tissue-specific expression in the brain. Mol. Immunol. 38: 65-72.
8. Sen, R. 2006. Control of B lymphocyte apoptosis by the transcription factor NF-κB. Immunity 25: 871-883.
9. Schram, B. R., and T. L. Rothstein. 2003. NF-κB is required for surface Iginduced Fas resistance in B cells. J. Immunol. 170: 3118-3124.
10. Lalmanach-Girard, A. C., T. C. Chiles, D. C. Parker, and T. L. Rothstein. 1993. T cell-dependent induction of NF-κB in B cells. J. Exp. Med. 177: 1215-1219.
11. Francis, D. A., J. G. Karras, X. Y. Ke, R. Sen, and T. L. Rothstein. 1995. Induction of the transcription factors NF-κB, AP-1 and NF-AT during B cell stimulation through the CD40 receptor. Int. Immunol. 7: 151-161.
12. Berberich, I., G. L. Shu, and E. A. Clark. 1994. Cross-linking CD40 on B cells rapidly activates nuclear factor-κB. J. Immunol. 153: 4357-4366. (Pubitemid 24346830)
13. Cherry, S. R., D. Biniszkiewicz, L. van Parijs, D. Baltimore, and R. Jaenisch. 2000. Retroviral expression in embryonic stem cells and hematopoietic stem cells. Mol. Cell Biol. 20: 7419-7426.
14. Holodick, N. E., K. J. Repetny, X. Zhong, and T. L. Rothstein. 2009. Adult bone marrow generates CD5+ B1 cells containing abundant N-region additions. Eur. J. Immunol., in press.
15. Mizuno, T., and T. L. Rothstein. 2003. Cutting edge: CD40 engagement eliminates the need for Bruton's tyrosine kinase in B cell receptor signaling for NF-κB. J. Immunol. 170: 2806-2810. (Pubitemid 36302149)
16. Mizuno, T., and T. L. Rothstein. 2005. B cell receptor (BCR) cross-talk: CD40 engagement creates an alternate pathway for BCR signaling that activates IκB kinase/IκBα/NF-κB without the need for PI3K and phospholipase Cγ. J. Immunol. 174: 6062-6070. (Pubitemid 40663794)
17. Frances, R., J. R. Tumang, and T. L. Rothstein. 2005. B-1 cells are deficient in Lck: defective B cell receptor signal transduction in B-1 cells occurs in the absence of elevated Lck expression. J. Immunol. 175: 27-31.
18. Lane, P., T. Brocker, S. Hubele, E. Padovan, A. Lanzavecchia, and F. McConnell. 1993. Soluble CD40 ligand can replace the normal T cell-derived CD40 ligand signal to B cells in T cell-dependent activation. J. Exp. Med. 177: 1209-1213.
19. Van Parijs, L., Y. Refaeli, J. D. Lord, B. H. Nelson, A. K. Abbas, and D. Baltimore. 1999. Uncoupling IL-2 signals that regulate T cell proliferation, survival, and Fas-mediated activation-induced cell death. Immunity 11: 281-288. (Pubitemid 29463236)
20. Repetny, K. J., X. Zhong, N. E. Holodick, T. L. Rothstein, and U. Hansen. 2009. LBP-1a binds Sμ and Sα, but not Sκ1, immunoglobulin switch regions in vivo, and represses heavy chain class switching only to IgA, but not to IgG1. Eur. J. Immunol. 39: 1387-1394.
21. Gilmore, T. D. 2006. Introduction to NF-κB: players, pathways, perspectives. Oncogene 25: 6680-6684.
22. Hoffmann, A., and D. Baltimore. 2006. Circuitry of nuclear factor κB signaling. Immunol. Rev. 210: 171-186.
23. Sarma, V., Z. Lin, L. Clark, B. M. Rust, M. Tewari, R. J. Noelle, and V. M. Dixit. 1995. Activation of the B-cell surface receptor CD40 induces A20, a novel zinc finger protein that inhibits apoptosis. J. Biol. Chem. 270: 12343-12346.
24. Goldstein, M. D., M. A. Debenedette, D. Hollenbaugh, and T. H. Watts. 1996. Induction of costimulatory molecules B7-1 and B7-2 in murine B cells: the CBA/N mouse reveals a role for Bruton's tyrosine kinase in CD40-mediated B7 induction. Mol. Immunol. 33: 541-552.
25. Vaidyanathan, H., J. D. Gentry, A. Weatherman, S. D. Schwartzbach, and T. M. Petro. 2001. Differential response of the murine IL-12 p35 gene to lipopolysaccharide compared with interferon-γ and CD40 ligation. Cytokine 16: 1-9.
26. Li, Q., and I. M. Verma. 2002. NF-γB regulation in the immune system. Nat. Rev. Immunol. 2: 725-734.
27. Romieu-Mourez, R., M. Solis, A. Nardin, D. Goubau, V. Baron-Bodo, R. Lin, B. Massie, M. Salcedo, and J. Hiscott. 2006. Distinct roles for IFN regulatory factor (IRF)-3 and IRF-7 in the activation of antitumor properties of human macrophages. Cancer Res. 66: 10576-10585.
28. Lim, W., K. Gee, S. Mishra, and A. Kumar. 2005. Regulation of B7.1 costimulatory molecule is mediated by the IFN regulatory factor-7 through the activation of JNK in lipopolysaccharide-stimulated human monocytic cells. J. Immunol. 175: 5690-5700.
29. Goriely, S., C. Molle, M. Nguyen, V. Albarani, N. O. Haddou, R. Lin, D. De Wit, V. Flamand, F. Willems, and M. Goldman. 2006. Interferon regulatory factor 3 is involved in Toll-like receptor 4 (TLR4)- and TLR3-induced IL-12p35 gene activation. Blood 107: 1078-1084.
30. Basso, K., U. Klein, H. Niu, G. A. Stolovitzky, Y. Tu, A. Califano, G. Cattoretti, and R. Dalla-Favera. 2004. Tracking CD40 signaling during germinal center development. Blood 104: 4088-4096.
31. Saito, M., J. Gao, K. Basso, Y. Kitagawa, P. M. Smith, G. Bhagat, A. Pernis, L. Pasqualucci, and R. Dalla-Favera. 2007. A signaling pathway mediating downregulation of BCL6 in germinal center B cells is blocked by BCL6 gene alterations in B cell lymphoma. Cancer Cell 12: 280-292. (Pubitemid 47333420)
32. Allman, D., A. Jain, A. Dent, R. R. Maile, T. Selvaggi, M. R. Kehry, and L. M. Staudt. 1996. BCL-6 expression during B-cell activation. Blood 87: 5257-5268.
33. Niu, H., G. Cattoretti, and R. Dalla-Favera. 2003. BCL6 controls the expression of the B7-1/CD80 costimulatory receptor in germinal center B cells. J. Exp. Med. 198: 211-221.
34. Klein, U., S. Casola, G. Cattoretti, Q. Shen, M. Lia, T. Mo, T. Ludwig, K. Rajewsky, and R. Dalla-Favera. 2006. Transcription factor IRF4 controls plasma cell differentiation and class-switch recombination. Nat. Immunol. 7: 773-782.
35. Sciammas, R., A. L. Shaffer, J. H. Schatz, H. Zhao, L. M. Staudt, and H. Singh. 2006. Graded expression of interferon regulatory factor-4 coordinates isotype switching with plasma cell differentiation. Immunity 25: 225-236.
36. Shen, Y., J. Iqbal, L. Xiao, R. C. Lynch, A. Rosenwald, L. M. Staudt, S. Sherman, K. Dybkaer, G. Zhou, J. D. Eudy, J. Delabie, T. W. McKeithan, and W. C. Chan. 2004. Distinct gene expression profiles in different B-cell compartments in human peripheral lymphoid organs. BMC Immunol. 5: 20.
37. Lin, K. I., C. Tunyaplin, and K. Calame. 2003. Transcriptional regulatory cascades controlling plasma cell differentiation. Immunol. Rev. 194: 19-28.
38. Fukuda, T., T. Yoshida, S. Okada, M. Hatano, T. Miki, K. Ishibashi, S. Okabe, H. Koseki, S. Hirosawa, M. Taniguchi, N. Miyasaka, and T. Tokuhisa. 1997. Disruption of the Bcl6 gene results in an impaired germinal center formation. J. Exp. Med. 186: 439-448.
39. Tunyaplin, C., A. L. Shaffer, C. D. Angelin-Duclos, X. Yu, L. M. Staudt, and K. L. Calame. 2004. Direct repression of prdm1 by Bcl-6 inhibits plasmacytic differentiation. J. Immunol. 173: 1158-1165. (Pubitemid 38924291)
40. Shaffer, A. L., K. I. Lin, T. C. Kuo, X. Yu, E. M. Hurt, A. Rosenwald, J. M. Giltnane, L. Yang, H. Zhao, K. Calame, and L. M. Staudt. 2002. Blimp-1 orchestrates plasma cell differentiation by extinguishing the mature B cell gene expression program. Immunity 17: 51-62.
41. Shapiro-Shelef, M., K. I. Lin, L. J. McHeyzer-Williams, J. Liao, M. G. McHeyzer-Williams, and K. Calame. 2003. Blimp-1 is required for the formation of immunoglobulin secreting plasma cells and pre-plasma memory B cells. Immunity 19: 607-620.
42. Horcher, M., A. Souabni, and M. Busslinger. 2001. Pax5/BSAP maintains the identity of B cells in late B lymphopoiesis. Immunity 14: 779-790.
43. Lin, K. I., C. Angelin-Duclos, T. C. Kuo, and K. Calame. 2002. Blimp-1-dependent repression of Pax-5 is required for differentiation of B cells to immunoglobulin M-secreting plasma cells. Mol. Cell Biol. 22: 4771-4780.
44. Reimold, A. M., N. N. Iwakoshi, J. Manis, P. Vallabhajosyula, E. Szomolanyi-Tsuda, E. M. Gravallese, D. Friend, M. J. Grusby, F. Alt, and L. H. Glimcher. 2001. Plasma cell differentiation requires the transcription factor XBP-1. Nature 412: 300-307.
45. Shaffer, A. L., M. Shapiro-Shelef, N. N. Iwakoshi, A. H. Lee, S. B. Qian, H. Zhao, X. Yu, L. Yang, B. K. Tan, A. Rosenwald, et al. 2004. XBP1, downstream of Blimp-1, expands the secretory apparatus and other organelles, and increases protein synthesis in plasma cell differentiation. Immunity 21: 81-93.
46. Yoshida, H., T. Matsui, A. Yamamoto, T. Okada, and K. Mori. 2001. XBP1 mRNA is induced by ATF6 and spliced by IRE1 in response to ER stress to produce a highly active transcription factor. Cell 107: 881-891.
47. Niu, H., B. H. Ye, and R. Dalla-Favera. 1998. Antigen receptor signaling induces MAP kinase-mediated phosphorylation and degradation of the BCL-6 transcription factor. Genes Dev. 12: 1953-1961. (Pubitemid 28323870)
48. Bereshchenko, O. R., W. Gu, and R. Dalla-Favera. 2002. Acetylation inactivates the transcriptional repressor BCL6. Nat. Genet. 32: 606-613.
49. Calame, K. L., K. I. Lin, and C. Tunyaplin. 2003. Regulatory mechanisms that determine the development and function of plasma cells. Annu. Rev. Immunol. 21: 205-230.
50. Allen, C. D., T. Okada, and J. G. Cyster. 2007. Germinal-center organization and cellular dynamics. Immunity 27: 190-202.
51. Huntington, N. D., Y. Xu, H. Puthalakath, A. Light, S. N. Willis, A. Strasser, and D. M. Tarlinton. 2006. CD45 links the B cell receptor with cell survival and is required for the persistence of germinal centers. Nat. Immunol. 7: 190-198.
52. Meyer-Hermann, M. E., P. K. Maini, and D. Iber. 2006. An analysis of B cell selection mechanisms in germinal centers. Math. Med. Biol. 23: 255-277.
53. Sole, C., X. Dolcet, M. F. Segura, H. Gutierrez, M. T. Diaz-Meco, R. Gozzelino, D. Sanchis, J. R. Bayascas, C. Gallego, J. Moscat, A. M. Davies, and J. X. Comella. 2004. The death receptor antagonist FAIM promotes neurite outgrowth by a mechanism that depends on ERK and NF-κB signaling. J. Cell Biol. 167: 479-492.
54. Hemond, M., T. L. Rothstein, and G. Wagner. 2009. Fas apoptosis inhibitory molecule contains a novel β-sandwich in contact with a partially ordered domain. J. Mol. Biol. 386: 1024-1037.
55. Naismith, J. H., and S. R. Sprang. 1998. Modularity in the TNF-receptor family. Trends Biochem. Sci. 23: 74-79.
56. Vogel, L. A., and R. J. Noelle. 1998. CD40 and its crucial role as a member of the TNFR family. Semin. Immunol. 10: 435-442.
57. Lanave, C., A. M. Colangelo, C. Saccone, and L. Alberghina. 2007. Molecular evolution of the neurotrophin family members and their Trk receptors. Gene 394: 1-12.